BC02 Role of platelet-rich plasma in atrophic acne scars along with microneedling and subcision

Shashank Bhargava
DOI: https://doi.org/10.1093/bjd/ljae090.142
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract Atrophic acne scarring is one of the most common sequel of acne vulgaris. The objective of this study was to evaluate the role of platelet-rich plasma (PRP) as adjunctive therapy to a combined subcision and needling treatment in severe (grade 4) atrophic acne scarring. In total 78 patients with grade 4 atrophic acne scars were randomly divided into two groups with 39 patients each: group A underwent three sessions of subcision and microneedling, while group B had three treatments of subcision, needling, and topical application of PRP. The sessions were repeated every 4 weeks. Scar grading was assessed 6 months following the final session. The participant’s assessment of treatment response was also considered. Scar improvement by ≥ 50% was reported significantly more often by patients in group B than in group A (P = 0.025). There were 11 patients from group B who improved by two grades, in comparison with only three from group A. The physician’s evaluation of improvement correlated with the patients’ own assessments: 50% of patients in group A and 67% in group B showed improvement of 25–49% and 50–74%, respectively. The mean duration of downtime was shorter among patients in group B than in group (21.1 vs. 32.9 h, respectively). Icepick scars showed the least improvement when compared with other variants of atrophic scars. In conclusion, PRP definitely works as an adjuvant modality to treat atrophic acne scars.
dermatology
What problem does this paper attempt to address?